ISSFAL 2010 dinner debate: Healthy fats for healthy hearts - Annotated report of a scientific discussion

Annals of Nutrition and Metabolism

Volumn 58, Issue 1, 2011, Pages 59-65

  Nettleton, Joyce A ^a   Koletzko, Berthold ^b   Hornstra, Gerard ^c  

^a ScienceVoice Consulting   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Healthy fats; Heart disease; Omega 6 polyunsaturates; Polyunsaturates; Recommended omega 6 intakes; Saturates

Indexed keywords

FAT; FATTY ACID; LINOLEIC ACID; LIPID; OMEGA 6 FATTY ACID; SATURATED FATTY ACID;

CARDIOVASCULAR DISEASE; CONFERENCE PAPER; FAT INTAKE; HEART; HUMAN; MEDICAL LITERATURE; MEDICAL SOCIETY; MORTALITY; PRIORITY JOURNAL; RISK REDUCTION;

CONGRESSES AS TOPIC; DIET; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HEART DISEASES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 79952842888     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324749     Document Type: Conference Paper

References (75)

1. Blackburn DG: Lactation: historical patterns and potential for manipulation. J Dairy Sci 1993; 76: 3195-3212.
2. German JB, Dillard CJ: Saturated fats: a perspective from lactation and milk composition. Lipids 2010; 45: 915-923.
3. Elwood PC, Pickering JE, Givens DI, Gallacher JE: The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids 2010; 45: 925-939.
4. Lin J, Yang R, Tarr PT, Wu PH, Handschin C, Li S, Yang W, Pei L, Uldry M, Tontonoz P, Newgard CB, Spiegelman BM: Hyperlipidemic effects of dietary saturated fats mediated through PGC-1 β coactivation of SREBP. Cell 2005; 120: 261-273. (Pubitemid 40174768)
5. Magkos F: Basal very low-density lipoprotein metabolism in response to exercise: mechanisms of hypotriacylglycerolemia. Prog Lipid Res 2009; 48: 171-190.
6. Rohas LM, St-Pierre J, Uldry M, Jager S, Handschin C, Spiegelman BM: A fundamental system of cellular energy homeostasis regulated by PGC-1 α . Proc Natl Acad Sci USA 2007; 104: 7933-7938. (Pubitemid 47185854)
7. Mozaffarian D, Rimm EB, Herrington DM: Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutr 2004; 80: 1175-1184. (Pubitemid 41350676)
8. Keys A, Anderson JT, Grande F: Serum cholesterol response to changes in the diet. IV. Particular saturated fatty acids in the diet. Metabolism 1965; 14: 776-787.
9. Hegsted DM, McGandy RB, Myers ML, Stare FJ: Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 1965; 17: 281-295.
10. Siri PW, Krauss RM: Influence of dietary carbohydrate and fat on LDL and HDL particle distributions. Curr Atheroscler Rep 2005; 7: 455-459. (Pubitemid 43033771)
11. Jakobsen MU, Dethlefsen C, Joensen AM, Stegger J, Tjonneland A, Schmidt EB, Overvad K: Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am J Clin Nutr 2010; 91: 1764-1768.
12. Parks EJ, Hellerstein MK: Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr 2000; 71: 412-433. (Pubitemid 30061218)
13. Teegala SM, Willett WC, Mozaffarian D: Consumption and health effects of trans fatty acids: a review. J AOAC Int 2009; 92: 1250-1257.
14. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM: Saturated fatty acids and risk of coronary heart disease: modulation by replacement nutrients. Curr Atheroscler Rep 2010; 12: 384-390.
15. Jakobsen MU, O'Reilly EJ, Heitmann BL, Pereira MA, Balter K, Fraser GE, Goldbourt U, Hallmans G, Knekt P, Liu S, Pietinen P, Spiegelman D, Stevens J, Virtamo J, Willett WC, Ascherio A: Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009; 89: 1425-1432.
16. Mozaffarian D, Micha R, Wallace S: Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010; 7:e1000252.
17. Niinikoski H, Lagstrom H, Jokinen E, Siltala M, Ronnemaa T, Viikari J, Raitakari OT, Jula A, Marniemi J, Nanto-Salonen K, Simell O: Impact of repeated dietary counseling between infancy and 14 years of age on dietary intakes and serum lipids and lipoproteins: The STRIP study. Circulation 2007; 116: 1032-1040. (Pubitemid 47329568)
18. Lindeberg S, Lundh B: Apparent absence of stroke and ischaemic heart disease in a traditional Melanesian island: a clinical study in Kitava. J Intern Med 1993; 233: 269-275. (Pubitemid 23100313)
19. Lindeberg S, Eliasson M, Lindahl B, Ahren B: Low serum insulin in traditional Pacific Islanders - the Kitava study. Metabolism 1999; 48: 1216-1219. (Pubitemid 29496066)
20. Lindeberg S, Nilsson-Ehle P, Terent A, Vessby B, Schersten B: Cardiovascular risk factors in a Melanesian population apparently free from stroke and ischaemic heart disease: the Kitava study. J Intern Med 1994; 236: 331-340. (Pubitemid 24283073)
21. Mann GV, Spoerry A, Gray M, Jarashow D: Atherosclerosis in the Masai. Am J Epidemiol 1972; 95: 26-37.
22. Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, Ripatti S, Aulchenko YS, Zhang W, Yuan X, Lim N, Luan J, Ashford S, Wheeler E, Young EH, Hadley D, Thompson JR, Braund PS, Johnson T, Struchalin M, Surakka I, Luben R, Khaw KT, Rodwell SA, Loos RJ, Boekholdt SM, Inouye M, Deloukas P, Elliott P, Schlessinger D, Sanna S, Scuteri A, Jackson A, Mohlke KL, Tuomilehto J, Roberts R, Stewart A, Kesaniemi YA, Mahley RW, Grundy SM, McArdle W, Cardon L, Waeber G, Vollenweider P, Chambers JC, Boehnke M, Abecasis GR, Salomaa V, Jarvelin MR, Ruokonen A, Barroso I, Epstein SE, Hakonarson HH, Rader DJ, Reilly MP, Witteman JC, Hall AS, Samani NJ, Strachan DP, Barter P, van Duijn CM, Kooner JS, Peltonen L, Wareham NJ, McPherson R, Mooser V, Sandhu MS: Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2010; 30: 2264-2276.
23. Chang MH, Yesupriya A, Ned RM, Mueller PW, Dowling NF: Genetic variants associated with fasting blood lipids in the US. Population: Third National Health and Nutrition Examination Survey. BMC Med Genet 2010; 11: 62.
24. Yoshida T, Kato K, Yokoi K, Oguri M, Watanabe S, Metoki N, Yoshida H, Satoh K, Aoyagi Y, Nozawa Y, Yamada Y: Association of genetic variants with myocardial infarction in japanese individuals with different lipid profiles. Int J Mol Med 2010; 25: 607-616.
25. Kraemer FB, Greenfield M, Tobey TA, Reaven GM: Effects of moderate increases in dietary polyunsaturated:saturated fat on plasma triglyceride and cholesterol levels in man. Br J Nutr 1982; 47: 259-266. (Pubitemid 12108746)
26. Laws A, Jeppesen JL, Maheux PC, Schaaf P, Chen YD, Reaven GM: Resistance to insulinstimulated glucose uptake and dyslipidemia in Asian Indians. Arterioscler Thromb 1994; 14: 917-922.
27. Palaniappan LP, Kwan AC, Abbasi F, Lamendola C, McLaughlin TL, Reaven GM: Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women. Metabolism 2007; 56: 899-904. (Pubitemid 46890971)
28. Gupta R, Joshi P, Mohan V, Reddy KS, Yusuf S: Epidemiology and causation of coronary heart disease and stroke in India. Heart 2008; 94: 16-26.
29. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM: Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr 2010; 91: 502-509.
30. Craig WJ: Health effects of vegan diets. Am J Clin Nutr 2009; 89: 1627S-1633S.
31. Craig WJ, Mangels AR: Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc 2009; 109: 1266-1282.
32. Palsdottir V, Wickman A, Andersson N, Hezaveh R, Olsson B, Gabrielsson BG, Strandvik B: Postnatal deficiency of essential fatty acids in mice results in resistance to diet-induced obesity and low plasma insulin during adulthood. Prostaglandins Leukot Essent Fatty Acids 2011; 84: 85-92.
33. Hellström N (ed): A Social Hygienic Investigation in the Counties of Västerbotten and Norrbotten. Lund, Håkan Ohlsson, 1934.
34. Lands B: A critique of paradoxes in current advice on dietary lipids. Prog Lipid Res 2008; 47: 77-106.
35. Harris WS, Mozaffarian D, Rimm E, Kris- Etherton P, Rudel LL, Appel LJ, Engler MM, Engler MB, Sacks F: Omega-6 fatty acids and risk for cardiovascular disease. A science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009; 119: 902-907.
36. Roberts DC: Dietary factors in the fall in coronary heart disease mortality. Prostaglandins Leukot Essent Fatty Acids 1991; 44: 97-101.
37. Block RC, Harris WS, Reid KJ, Spertus JA: Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes? Am Heart J 2008; 156: 1117-1123.
38. Mensink RP, Zock PL, Kester AD, Katan MB: Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003; 77: 1146-1155. (Pubitemid 44858429)
39. Micha R, Mozaffarian D: Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids 2010; 45: 893-905.
40. Czernichow S, Thomas D, Bruckert E: n-6 fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations. Br J Nutr 2010; 104: 788-796.
41. Stampfer MJ, Colditz GA: Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63.
42. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH: Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453-461. (Pubitemid 26269944)
43. Grodstein F: Invited commentary: can selection bias explain the cardiovascular benefits of estrogen replacement therapy? Am J Epidemiol 1996; 143: 979-982; discussion 983-984.
44. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD: Postmenopausal hormone replacement therapy: scientific review. JAMA 2002; 288: 872-881.
45. Kris-Etherton P, Fleming J, Harris WS: The debate about n-6 polyunsaturated fatty acid recommendations for cardiovascular health. J Am Diet Assoc 2010; 110: 201-204.
46. Kris-Etherton P, Harris WS: Dietary omega- 6 polyunsaturated fatty acids - important for heart health. Clin Nutr Insight 2009; 35: 1-5.
47. Leren P: The Oslo diet-heart study. Elevenyear report. Circulation 1970; 42: 935-942.
48. Leren P: The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Med Scand Suppl 1966; 466: 1-92.
49. Rose GA, Thomson WB, Williams RT: Corn oil in treatment of ischaemic heart disease. Br Med J 1965;1:1531-1533.
50. Frantz ID Jr, Dawson EA, Ashman PL, Gatewood LC, Bartsch GE, Kuba K, Brewer ER: Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey. Arteriosclerosis 1989; 9: 129-135. (Pubitemid 19046099)
51. Woodhill JM, Palmer AJ, Leelarthaepin B, McGilchrist C, Blacket RB: Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Adv Exp Med Biol 1978; 109: 317-330.
52. Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM: n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr 2010; 104: 1586-1600.
53. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J: Mediterranean α -linolenic acidrich diet in secondary prevention of coronary heart disease. Lancet 1994; 343: 1454-1459. (Pubitemid 24176333)
54. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99: 779-785. (Pubitemid 29083018)
55. Pella D, Dubnov G, Singh RB, Sharma R, Berry EM, Manor O: Effects of an Indo- Mediterranean diet on the omega-6/omega-3 ratio in patients at high risk of coronary artery disease: the Indian paradox. World Rev Nutr Diet 2003; 92: 74-80.
56. Dubnov G, Berry EM: Omega-6/omega-3 fatty acid ratio: the Israeli paradox. World Rev Nutr Diet 2003; 92: 81-91.
57. Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE: Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr 2006; 83: 1483S-1493S. (Pubitemid 44713089)
58. Clark KJ, Makrides M, Neumann MA, Gibson RA: Determination of the optimal ratio of linoleic acid to alpha-linolenic acid in infant formulas. J Pediatr 1992; 120:S151-S158.
59. Munakata M, Nishikawa M, Togashi N, Nio E, Kobayashi Y, Omura K, Haginoya K, Tanaka S, Abe T, Hishinuma T, Chida N, Tsuchiya S, Onuma A: The nutrient formula containing eicosapentaenoic acid and docosahexaenoic acid benefits the fatty acid status of patients receiving long-term enteral nutrition. Tohoku J Exp Med 2009; 217: 23-28.
60. Dayton S, Hashimoto S, Pearce ML: Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation 1965; 32: 911-924.
61. Friesen RW, Innis SM: Linoleic acid is associated with lower long-chain n-6 and n-3 fatty acids in red blood cell lipids of Canadian pregnant women. Am J Clin Nutr 2010; 91: 23-31.
62. Eaton SB, Eaton SB 3rd, Sinclair AJ, Cordain L, Mann NJ: Dietary intake of long-chain polyunsaturated fatty acids during the paleolithic. World Rev Nutr Diet 1998; 83: 12-23. (Pubitemid 128081428)
63. Kuipers RS, Luxwolda MF, Dijck-Brouwer DA, Eaton SB, Crawford MA, Cordain L, Muskiet FA: Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet. Br J Nutr 2010; 104:1666-1687.
64. Ervin RB, Wright JD, Wang CY, Kennedy- Stephenson J: Dietary intake of fats and fatty acids for the United States population: 1999- 2000. Adv Data 2004; 1-6.
65. Alveheim A O-HD, Robert P, Madsen L, Kristiansen K, Frøyland L, Hibbeln J: Dietary Linoleic Acid Promotes Hypereactive Hepatic 2-Arachidonoyl-Glycerol And Contributes to Diet-Induced Obesity. Maastricht, International Society for the Study of Fatty Acids and Lipids, 2010, p 106.
66. Andre A, Gonthier MP: The endocannabinoid system: its roles in energy balance and potential as a target for obesity treatment. Int J Biochem Cell Biol 2010; 42: 1788-1801.
67. Massa F, Mancini G, Schmidt H, Steindel F, Mackie K, Angioni C, Oliet SH, Geisslinger G, Lutz B: Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. J Neurosci 2010; 30: 6273-6281.
68. Field AE, Willett WC, Lissner L, Colditz GA: Dietary fat and weight gain among women in the Nurses' Health Study. Obesity (Silver Spring) 2007; 15: 967-976. (Pubitemid 46740972)
69. Mohrhauer H, Holman RT: The effect of dose level of essential fatty acids upon fatty acid composition of the rat liver. J Lipid Res 1963; 4: 151-159.
70. Holman RT: The slow discovery of the importance of omega 3 essential fatty acids in human health. J Nutr 1998; 128: 427S-433S. (Pubitemid 28090397)
71. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
72. Buchwald H, Campos CT, Boen JR, Nguyen PA, Williams SE: Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH). J Am Coll Cardiol 1995; 26: 351-357.
73. Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke- Barwolf C, Holme I, Kesaniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R: Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008; 359: 1343-1356.
74. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G: Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): A randomised, doubleblind, placebo-controlled trial. Lancet 2008; 372: 1231-1239.
75. Harris WS: The omega-3 index as a risk factor for coronary heart disease. Am J Clin Nutr 2008; 87: 1997S-2002S. (Pubitemid 351872681)